Matthew Zinder

About Matthew Zinder

Regulatory affairs leader with experience overseeing regulatory strategy, CMC, labeling, and advertising and promotion, with the versatility to contribute to corporate business development, operational, and financial goals. Over 15 years of experience in the pharmaceutical industry providing strong leadership and strategic capabilities. Significant contributions to drug development from preclinical through clinical and commercial stages. Successful track record developing and managing regulatory strategies across a range of therapeutic areas and products and leading interactions with health authorities. Extensive experience developing key regulatory submissions (e.g. INDs, NDAs, BLAs, global CTAs, etc.) and working collaboratively with cross-functional team members, development partners, and external consultants for both small and large molecules for high unmet need diseases. Proven ability to build and lead high performance teams and deliver results in matrixed organizations. Accomplished at managing budgets, project deliverables, defining project scope, establishing schedules, and fostering team relationships. Experienced implementing and and maintaining standard operating procedures, departmental processes and systems, and compliance programs within a regulated environment.

Experience

1. Senior Vice President, Regulatory Affairs

   Spyre Therapeutics

   Dec 2025 — Present

Education

• University of California, Berkeley

  Bachelor's degree, Biochemistry

• University of California, Berkeley

  Master's degree, Translational Medicine

• University of California, San Francisco

  Master's degree, Translational Medicine